×
收藏-健康|会(x)员访问记?/h3>
| |页标题Q? | |
×
注册健康|用?/h3>
| ??名：(x) | ||
|---|---|---|
| ?p?人：(x) | ?nbsp; 别：(x) | |
| ?nbsp; 码：(x) | ||
| 重复密码Q?/th> | ||
| ?sh)子邮箱Q?/th> | ||
| 固定?sh)话Q?/th> | ||
| ?nbsp; 真：(x) | ||
| ?nbsp; 机：(x) | ||
| 单位名称Q?/th> | ||
| 通信地址Q?/th> | ||
| 首选栏目：(x) | ||
| 我已l认真阅dƈ同意《健L(fng)服务条款?/a> | ||
| 定注册 | ||
国FDA和Telangana DCA在国FDA许可的工厂进行联合检查和审计
作者：(x)xuezhe 来源Q互联网 点击敎ͼ(x)0 更新旉Q?024/2/6 16:47:12
相关q接
2023q美国FDA批准新药中的优先审评药品
FDA 发布l合产品使用者付费定E指?/a>
Genetic Signatures?EasyScreen gastrointestinal parasite detection kit receives US FDA clearance
Adicet Bio receives US FDA fast track designation for ADI-001 for class IV lupus nephritis
US EPA, US FDA & USDA issue joint regulatory plan for biotechnology
q哲医药“舒沃替”新适应症再获FDAH破性疗法认?/a>
荣昌生物“泰它西普”获FDA快速通道资格
鲁南制药注射用唑来膦酸浓溶液L(fng)国FDA批准
FDA 发布l合产品使用者付费定E指?/a>
Genetic Signatures?EasyScreen gastrointestinal parasite detection kit receives US FDA clearance
Adicet Bio receives US FDA fast track designation for ADI-001 for class IV lupus nephritis
US EPA, US FDA & USDA issue joint regulatory plan for biotechnology
q哲医药“舒沃替”新适应症再获FDAH破性疗法认?/a>
荣昌生物“泰它西普”获FDA快速通道资格
鲁南制药注射用唑来膦酸浓溶液L(fng)国FDA批准